Outcomes | Priority |
---|---|
Potential benefit of reduced | |
 All-cause mortality | Critical |
 CVD-related mortality | Critical |
 Macrovascular complications (e.g., myocardial infarction, stroke, peripheral arterial disease) | Critical |
 Microvascular complications (e.g., renal disease, retinal disease) | Important |
Potential harm of increased | |
 Adverse effects of antihypertensive treatment | Important |
 Overdiagnosis a | Important |
 Psychosocial impact of screening | Important |